Eligard 45 mg (Leuprolide Acetate POWDER FOR SUSPENSION, SUSTAINED-RELEASE) 45 MG

Eligard 45 mg is a sustained-release powder for suspension used for hormone-related conditions. This subcutaneous injection contains leuprolide acetate and is manufactured by Tolmar International Ltd.

Strength

45 MG

Pack Size

45MG

Manufacturer / TM Owner

TOLMAR INTERNATIONAL LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eligard 45 mg is primarily used for the management of hormone-sensitive conditions. It works by reducing the production of certain hormones in the body. This medication is often prescribed for conditions that respond to hormone regulation, such as specific types of cancer or hormonal imbalances.

Side Effects

Common effects of Eligard 45 mg may include temporary discomfort at the injection site, hot flashes, and changes in bone density. Some individuals may experience fatigue or mood swings. These effects vary and should be discussed with a healthcare provider.

Precautions & Warnings

Eligard 45 mg should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and use it as directed. Patients should be aware of potential side effects and report any severe reactions immediately.

Avoid Interactions

Eligard 45 mg may interact with other medications, including those that affect hormone levels or the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

Frequently Asked Questions

Eligard 45 mg is used for the management of hormone-sensitive conditions, often related to cancer or hormonal imbalances.

Eligard 45 mg is administered as a subcutaneous injection, typically by a healthcare professional.

Common side effects may include hot flashes, fatigue, and discomfort at the injection site.

Eligard 45 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Eligard 45 mg should be stored according to the instructions provided by the manufacturer to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.